Abstract
PURPOSE: To evaluate the role of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) as pre-operative markers for predicting extravesical disease and survival outcomes in patients undergoing radical cystectomy (RC) for urothelial carcinoma of the bladder (UCB).
MATERIALS AND METHODS: Data from 4335 patients undergoing RC for clinically non-metastatic UCB were analyzed. Multivariable logistic regression models were used to predict lymph node involvement and extravesical disease (defined as ≥pT3 and N0). Recurrence-free (RFS), cancer-specific (CSS), and overall survival (OS) were evaluated using multivariable Cox models. The accuracy of the models was assessed with receiver operating characteristics (ROC) curves and concordance-index.
RESULTS: Median LMR was 3.5 and median NLR was 2.7. Addition of LMR and NLR to a standard preoperative model improved its discrimination for prediction of lymph node metastasis by 4.5%. On multivariable analysis LMR and NLR independently predicted RFS, CSS, and OS. The discrimination of this model increased by adding LMR and NLR but was not significant.
CONCLUSIONS: LMR and NLR independently improved the preoperative prediction of lymph node metastasis and survival outcomes. As they are readily available, they could be integrated in a panel of preoperative markers helping selecting patients who have extravesical lymph node involvement and more aggressive disease.
Original language | English |
---|---|
Pages (from-to) | 455-461 |
Number of pages | 7 |
Journal | Journal of Surgical Oncology |
Volume | 115 |
Issue number | 4 |
DOIs | |
Publication status | Published - 15 Mar 2017 |
Keywords
- Age Factors
- Aged
- Biomarkers/blood
- Blood Cell Count
- Carcinoma, Transitional Cell/mortality
- Cystectomy
- Disease-Free Survival
- Female
- Humans
- Lymphatic Metastasis
- Lymphocytes/metabolism
- Male
- Middle Aged
- Monocytes/metabolism
- Multivariate Analysis
- Neutrophils/metabolism
- Prognosis
- Retrospective Studies
- Sex Factors
- Urinary Bladder Neoplasms/mortality